Publication

Animal models of type 2 diabetes, obesity and nonalcoholic steatohepatitis – clinical translatability and applicability in preclinical drug development

In: Krentz A., Weyer C., Hompesch M. (eds) Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Springer, Cham. pp 369-403, 2019

Hansen HH, Hansen G, Secher T, Feigh M, Veidal SS, Fosgerau K, Jelsing J, Vrang N

View publication

Subjects
db/db mouseDIO mouseTherapeutic AreaDIO ratZDF ratMouseob/ob mouseCDAA-HFD mouseMethod/EndpointCDAA-HFD ratDiabetesSpeciesAMLN DIO-NASH (AMLN DIO-MASH) mouseAMLN ob/ob-NASH (AMLN ob/ob-MASH) mouseRatNon-alcoholic steatohepatitis/Metabolic dysfunction-associated steatohepatitis (NASH/MASH)ObesityDrug discovery

Share this page

Resource Library

Related resources
Publication
GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
Publication
Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
Publication
Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake
Publication
An aldehyde responsive, cleavable linker for glucose responsive insulins

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top